S3 INVESTMENT CO INC Quick Quote: SEIH 0.00 (Even)
S3 Investment Company Subsidiary SINO UJE Awarded Exclusive Distribution Rights to Stomocur Brand Medical Devices for the Chinese Market
5/25/2006
TEMECULA, CA, May 25, 2006 (MARKET WIRE via COMTEX News Network) --
S3 Investment Company, Inc. (OTCBB: SEIH) announced today that its subsidiary SINO UJE, Ltd. has been awarded exclusive distribution rights from For Life GmbH of Berlin to market a wide range of Stomocur brand colostomy product throughout China. The Stomocur two-piece system has received China's State Food and Drug Administration (SFDA) approval and is permitted to be sold on the Chinese market.
EL GOBIERNO CHINO HA APROBADO LA COMERCIALIZACIÓN DEL PRODUCTO For Life's Stomocur EN EL MERCADO CHINO
"Earning exclusive rights to distribute For Life's Stomocur brand throughout China is yet another significant accomplishment by our team at SINO UJE," commented S3 chief executive officer Jim Bickel. "The selection of SINO UJE over the several other firms that had been in negotiations with For Life further establishes us as the premier distributor of high-end medical devices to the enormous, and still largely untapped, China market. We expect a number of doors will be opened as a result of this distribution agreement, both within China to additional medical suppliers and facilities, as well as in Europe to more manufacturing firms seeking a distributor familiar with the unique undertone and practices inherent to doing business in China."
ESPERAN QUE ESTA APROBACIÓN ABRA NUEVAS PUERTAS EN CONTRATOS, ASÍ COMO LA ENTRADA DEL PRODUCTO EN EUROPA
For Life manufactures high-quality medical devices that are reliable and provide support to their users "for life." Founded in 1990, its product lines have been growing in popularity both in Germany and around the world.
"As S3 increases the level of support it can provide to its subsidiary companies, SINO UJE will have the ability to sign an even greater number of exclusive distribution agreements with high-quality western companies such as For Life and fulfill orders as fast as they are received," added Mr. Bickel.
POSIBILIDAD DE CONSEGUIR NUEVOS CONTRATOS
About For Life of Berlin
Headquartered in Berlin, Germany, For Life has been developing and producing high-quality stoma products since 1990. The company has recently expanded its capacity through the addition of the latest technology in a specially constructed new factory. With this, and with the help of its motivated staff and management, For Life is able to satisfy the increasingly diverse requirements of an growing customer base.
About S3 Investment Company
S3 Investment Company, Inc. (http://www.s3investments.com) is an holding company with two subsidiaries doing business in the China market. S3 holds a 100% equity interest in Redwood Capital (http://www.redwoodcapinc.com), which assists private Chinese companies in accessing U.S. capital markets by utilizing a network of investment banking relationships, and a 51% equity interest in SINO UJE (http://www.sinouje.com), a non-stocking distributor of medical and industrial high-tech products to markets throughout China.
Any statements contained herein related to future events are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements. S3 Investment Company, Inc. undertakes no obligation to update any such statements to reflect actual events.
Contact: Gemini Financial Communications A. Beyer (951) 587-8072 Contact via http://www.marketwire.com/mw/emailprcntct?...ECA549BB759E85A Equiti-trend Advisors LLC Investor Communication Representatives Toll-Free (800) 585-6988
SOURCE: S3 Investment Company
